Q2 2025 Earnings Call Transcript August 11, 2025 Kymera Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Thank you, and welcome to the BiomX conference call to review the company's second quarter 2025 financial results and provide an update on our business and programs. Later today, we will file the ...

Q2 2025 Earnings Call Transcript August 12, 2025 Altimmune, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.32. Operator: Good morning, ladies and gentlemen, and ...

Positive ENLIGHTEN 2 Phase 3 results announced in June 2025 propel business activities in manufacturing, regulatory strategy and ENLIGHTEN clinical dataset analysis to advance path forward for LYR-210 ...

Cory Jubinville, LifeSci Capital: Asked about growth levers and timing for commercial payer contracts. Jeffs and Moomaw outlined plans for expanding prescriber breadth and depth, leveraging dosing ...

Some food memories linger like a perfect melody, playing on repeat in your mind—and the sausage roll at Rise’n Roll Bakery & Deli in Middlebury, Indiana, composes a symphony your taste buds won’t soon ...

HOUSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin” or the "Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates ...

Continues recruitment and opens US and EU sites for the Phase 2B/3 MIRACLE trial- 20+ additional clinical sites in Europe and the US expected to begin recruitment by the end of Q3 - Anticipated data ...

In terms of gender equality, the highly-specialised FIM Land Speed World Records discipline presents competitors ...